|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3B
|
|
pubmed:dateCreated |
1998-7-31
|
|
pubmed:abstractText |
In this study we investigated whether the presence of p53 antibodies in sera before of during/after radiation therapy can predict increased survival in patients with non-small cell lung cancer.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
0250-7005
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
18
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1999-2002
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:9677456-Adenocarcinoma,
pubmed-meshheading:9677456-Adult,
pubmed-meshheading:9677456-Aged,
pubmed-meshheading:9677456-Autoantibodies,
pubmed-meshheading:9677456-Carcinoma, Non-Small-Cell Lung,
pubmed-meshheading:9677456-Carcinoma, Squamous Cell,
pubmed-meshheading:9677456-Female,
pubmed-meshheading:9677456-Humans,
pubmed-meshheading:9677456-Lung Neoplasms,
pubmed-meshheading:9677456-Male,
pubmed-meshheading:9677456-Middle Aged,
pubmed-meshheading:9677456-Prognosis,
pubmed-meshheading:9677456-Tumor Suppressor Protein p53
|
|
pubmed:articleTitle |
P53 auto-antibodies in non-small cell lung cancer patients can predict increased life expectancy after radiotherapy.
|
|
pubmed:affiliation |
Department of Oncology, Akademiska Hospital, University of Uppsala, Sweden.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
